tradingkey.logo

Ozempic, Wegovy may cause rare eye condition, EMA says

ReutersJun 6, 2025 10:10 AM

- The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very rare side effect of Novo Nordisk's NOVOb.CO popular treatments Ozempic and Wegovy, it said on Friday.

The condition may affect up to 1 in 10,000 people taking semaglutide, the chemical name for Wegovy and Ozempic, the EMA said.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI